| Construction of clinical pathway for COVID-19 quasi-designated hospitals: experience from Zhongshan Hospital, Fudan University |
| Received:May 25, 2022 Revised:June 05, 2022 Click here to download the full text |
| Citation of this paper:Expert Group for Clinical Pathway of Minhang Stadium Quasi-designated Hospital in Shanghai.Construction of clinical pathway for COVID-19 quasi-designated hospitals: experience from Zhongshan Hospital, Fudan University[J].Chinese Journal of Clinical Medicine,2022,29(3):312-321 |
| Hits: 1135 |
| Download times: 265 |
|
| Abstract:In the prevention and control of Coronavirus Disease 2019 (COVID-19) in Shanghai in 2022, quasi-designated hospitals played an important role. Minhang Stadium Quasi-designated Hospital was among the first to admit COVID-19 patients, and had cured a large number of patients with comorbidities since its establishment. This article summarized the working experience in Minhang Stadium Quasi-designated Hospital concerning patient admission, treatments, nursing, and infection control, established the first clinical pathway of quasi-designated COVID-19 hospital in China and offered valuable experience of prevention and control of COVID-19 from Zhongshan Hospital, Fudan University. |
| keywords:coronavirus disease 2019 quasi-designated hospital clinical pathway comorbidity |
| HTML View Full Text View/Add Comment Download reader |